Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
出版年份 2019 全文链接
标题
Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
作者
关键词
-
出版物
ADVANCED MATERIALS
Volume -, Issue -, Pages 1805888
出版商
Wiley
发表日期
2019-02-14
DOI
10.1002/adma.201805888
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer
- (2018) Eun Jung Lee et al. ADVANCED MATERIALS
- PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy
- (2018) Xudong Zhang et al. ADVANCED MATERIALS
- Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
- (2018) Shuangjiang Yu et al. ADVANCED MATERIALS
- Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer
- (2018) Guangbao Yang et al. NANO LETTERS
- Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy
- (2018) Keman Cheng et al. NANO LETTERS
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
- (2018) Wantong Song et al. Nature Communications
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
- (2018) Bing Feng et al. ADVANCED MATERIALS
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
- (2017) Guangbao Yang et al. Nature Communications
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy
- (2017) Yuting Huang et al. Journal of Thoracic Disease
- Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy
- (2016) Dangge Wang et al. NANO LETTERS
- Durable antitumor responses to CD47 blockade require adaptive immune stimulation
- (2016) Jonathan T. Sockolosky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CD47 antibody suppresses tumour growth and augments the effect of chemotherapy treatment in hepatocellular carcinoma
- (2015) Jessica Lo et al. LIVER INTERNATIONAL
- CD47 blockade as another immune checkpoint therapy for cancer
- (2015) Robert H Vonderheide NATURE MEDICINE
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
- (2015) Rikke B. Holmgaard et al. Cell Reports
- CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
- (2014) D. R. Soto-Pantoja et al. CANCER RESEARCH
- Making Macrophages Eat Cancer
- (2013) M. H. Kershaw et al. SCIENCE
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now